Clinical trial

Next-Generation alzheImer'S Therapeutics

NCT06372587

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2023-12-19

PhaseNA

Study timeline

Study start (actual)2023-12-19Date precision: day

Registry last updated2024-04-18

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Alzheimer Diseaseunresolved

Interventions

genetically encoded engineered proteinsOTHER

Sponsors & collaborators

Fondazione Policlinico Universitario Agostino Gemelli IRCCSlead sponsor

Mapped research locations

RomaItaly1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06372587 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.